These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Pasquet S; Sovalat H; Hénon P; Bischoff N; Arkam Y; Ojeda-Uribe M; Bouar Rl; Rimelen V; Brink I; Dallemand R; Monassier JP Cytotherapy; 2009; 11(8):1002-15. PubMed ID: 19929464 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of ex vivo produced endothelial progenitor cells for autologous transplantation in primates. Qin M; Guan X; Zhang Y; Shen B; Liu F; Zhang Q; Ma Y; Jiang Y Stem Cell Res Ther; 2018 Jan; 9(1):14. PubMed ID: 29357928 [TBL] [Abstract][Full Text] [Related]
11. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Kawamoto A; Asahara T Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361 [TBL] [Abstract][Full Text] [Related]
12. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Leone AM; Rutella S; Bonanno G; Abbate A; Rebuzzi AG; Giovannini S; Lombardi M; Galiuto L; Liuzzo G; Andreotti F; Lanza GA; Contemi AM; Leone G; Crea F Eur Heart J; 2005 Jun; 26(12):1196-204. PubMed ID: 15734770 [TBL] [Abstract][Full Text] [Related]
13. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials. Velagapudi P; Turagam M; Kolte D; Khera S; Hyder O; Gordon P; Aronow HD; Leopold J; Abbott JD Cardiovasc Revasc Med; 2019 Mar; 20(3):215-219. PubMed ID: 29908826 [TBL] [Abstract][Full Text] [Related]
14. Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Wojakowski W; Tendera M Folia Histochem Cytobiol; 2005; 43(4):229-32. PubMed ID: 16382890 [TBL] [Abstract][Full Text] [Related]
15. Vascular Regeneration With New Sources of Endothelial Cells. Lee S; Lee SJ; Yoon YS Circ Res; 2019 Jan; 124(1):29-31. PubMed ID: 30605418 [TBL] [Abstract][Full Text] [Related]
17. Circulating Stem/Progenitor Cells as Prognostic Biomarkers in Macro- and Microvascular Disease: A Narrative Review of Prospective Observational Studies. Rigato M; Fadini GP Curr Med Chem; 2018; 25(35):4507-4517. PubMed ID: 28933297 [TBL] [Abstract][Full Text] [Related]
18. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Massa M; Rosti V; Ferrario M; Campanelli R; Ramajoli I; Rosso R; De Ferrari GM; Ferlini M; Goffredo L; Bertoletti A; Klersy C; Pecci A; Moratti R; Tavazzi L Blood; 2005 Jan; 105(1):199-206. PubMed ID: 15345590 [TBL] [Abstract][Full Text] [Related]
19. CD34+ autologous human stem cells in treating refractory angina. Perin EC; Willerson JT Circ Res; 2011 Aug; 109(4):351-2. PubMed ID: 21817161 [No Abstract] [Full Text] [Related]
20. Concurrent hypermulticolor monitoring of CD31, CD34, CD45 and CD146 endothelial progenitor cell markers for acute myocardial infarction. Shim Y; Nam MH; Hyuk SW; Yoon SY; Song JM Anal Chim Acta; 2015 Jan; 853():501-507. PubMed ID: 25467496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]